Milestone Pharmaceuticals (MIST) Short-term Investments (2018 - 2026)

Milestone Pharmaceuticals' Short-term Investments history runs 9 years deep, the most recent figure standing at $112.9 million for Q1 2026.

• Quarterly Short-term Investments rose 938.35% year-over-year to $112.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.9 million (up 938.35% YoY) and the FY2025 annual result came in at $32.9 million, down 25.87% from the prior year.
• Short-term Investments was $112.9 million for Q1 2026 at Milestone Pharmaceuticals, up from $32.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $112.9 million in Q1 2026 and bottomed at $918000.0 in Q2 2025.
• A 5-year average of $45.8 million and a median of $44.4 million in 2024 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2025 — Short-term Investments tumbled 98.69% — and 2026, when it soared 938.35%.
• Milestone Pharmaceuticals' Short-term Investments stood at $56.9 million in 2022, then declined by 8.26% to $52.2 million in 2023, then decreased by 14.94% to $44.4 million in 2024, then dropped by 25.87% to $32.9 million in 2025, then jumped by 243.02% to $112.9 million in 2026.
• Business Quant data shows MIST's Short-term Investments at $112.9 million in Q1 2026, $32.9 million in Q4 2025, and $35.9 million in Q3 2025.